Elessar wrote: » Wait, that's 1.1m total I assume as has been discussed recently? Not 1.1m extra vaccines on top of what we already got for q1?
Stark wrote: » 1.1m total
marno21 wrote: » 3.85m expected in Q2 atm so. Plus 1.1m from Q1 leaves us at 4.95m by end of Q2. Some of these will be J&J and some will be AstraZeneca who will be administering little 2nd doses in Q2 (just the March second doses in June). Should leave us with >80% of the adult population with one dose by Q2 end. I would sincerely hope we end up getting more than 3.85m doses in Q2.
political analyst wrote: » For what it's worth, Tracey O'Mahony has launched a legal challenge.https://gript.ie/barrister-tracey-omahony-launches-lockdown-challenge/
In the draining lymph nodes, we detected robust SARS-CoV-2 S-binding GC and PB responses in aspirates from 12 of 12 participants. These responses were detectable after the first immunization and increased after the second. ... These results with mRNA vaccines are superior to those seen after seasonal influenza virus vaccination in humans, where hemagglutinin-binding GC B cells were detected in only three of eight participants
S-specific PB pool that persists in the draining lymph nodes contained a substantial fraction of IgA+ cells. This observation is intriguing because it occurred after intramuscular rather than mucosal vaccination.
JTMan wrote: » Gavin Reilly reported ... Taoiseach says Boris Johnson "doesn't have surplus vaccines to give to Ireland right now". That does not sound like a no to me. Sounds like no for now but maybe the UK will give supplies to us at a later stage.
BigMo1 wrote: » Is there anything to point to us getting more Q2 supply though? Everything I've read up to now seems to point to less. I'm just scrapping for some hope, I'm to be married at the end of July so trying to cling onto any good news I can get.
ACitizenErased wrote: » So the Irish Times article pushed by a specific person on here yesterday is complete BS, as proven at the time
Wolf359f wrote: » I think they need to show a more clearer picture. Last year week 32-46: 6.8% of all cases were in HCW (2.3% of which where hospitalized) Week 48-8: 10.2% of all cases were in HCW (2.8% of which were hospitalized) Filtering out week 7-8 this year, it looks to be 9.2% of all cases are in HCW's. I could be completely wrong and reading reports wrong, all evidence worldwide points to the vaccine having a massive impact. I would just have thought we'd see a bigger drop in HCW's as a % of the general population.
KrustyUCC wrote: » That makes for disappointing reading Looks likely we will be missing out targets for Q2 as well
[Deleted User] wrote: » Per the 14 day epidemiological reports in the past 14 days 3.75% of 7,683 cases were healthcare setting acquired. In the 14 days to the 29th of January, this was 13% of 27,348 cases
astrofool wrote: » The horse will likely have long bolted at that stage, now is the time for them to help, not in 2-3 months time. Depends on what happens with AZ, who have said they'll meet their quotas in Q2, despite governments using the decreased estimates in planning. EU also working with J&J to speed up their manufacturing, and more Pfizer capacity coming online all the time. Hopefully this time it is a conservative amount that increases rather than decreases, however, if we get to 80% by June, that'll be great for the country.
marno21 wrote: » 3.85m expected in Q2 atm so. Plus 1.1m from Q1 leaves us at 4.95m by end of Q2. Some of these will be J&J and some will be AstraZeneca who will be administering little 2nd doses in Q2 (just the March second doses in June).Should leave us with >80% of the adult population with one dose by Q2 end. I would sincerely hope we end up getting more than 3.85m doses in Q2.
seamus wrote: » UK would have no basis to complain about the EU engaging in a little bit of vaccine nationalism at this stage .
Melanchthon wrote: » Whats the UK done apart from making sure that they have ring fenced their contracts? Also there is a massive difference between being open about what your going to do RE the USA, and changing the situation this late after condemning similar last year.
Hardyn wrote: » Well now. This is interesting.https://twitter.com/florian_krammer/status/1369668488500019209?s=20
jackryan34 wrote: » It means?
...revealed markedly reduced #specificity when applied to human sera from Africa...
brickster69 wrote: » So in other words just political bolloxhttps://twitter.com/nickgutteridge/status/1369643211837300740
titan18 wrote: » https://www.nytimes.com/2021/03/10/world/europe/eu-exports-vaccines.html EU are being too nice imo when we're not getting supplies promised. Particularly shipping to US who refuse to ship to anyone else atm
Hardyn wrote: » One of the findings of the South African Novavax trial was a similar attack rate between participants who previously had Covid and those who didn't. Novavax used their own in-house ELISA test to check for antibodies in the participants. This study suggests that ELISAs used in samples from Africa show markedly reduced specificity, possibly due to interference from local endemic pathogens. There's a possibility that the 30% seropositivity rate from the trial may have been an overestimate.
jackryan34 wrote: » Give me a bit room here, it wasn't intelligence that got me this far. Antibody tests don't work well on Africans? They work well on Europeans and Americans, yeah ok, hmmm Because of that the Novavax vaccine is now a very good vaccine and works well against SA variant